Raphael Pharmaceutical (RAPH) Net Cash Flow (2020 - 2025)
Raphael Pharmaceutical's (RAPH) quarterly Net Cash Flow came in at $42000.0 in Q4 2025, up 300.0% year-on-year from $10500.0 in Q4 2024, and up 347.06% quarter-over-quarter from -$17000.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Net Cash Flow (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has disclosed Net Cash Flow across 6 years of filings, most recently posting $42000.0 for Q4 2025.
- Net Cash Flow for Q4 2025 came in at $42000.0, up 300.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $26000.0 (up 112.26% YoY), and the FY2025 annual result was $26000.0, up 112.32% from the prior year.
- Net Cash Flow came in at $42000.0 for Q4 2025 at Raphael Pharmaceutical, up from -$17000.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $208000.0 in Q2 2021 to a low of -$250000.0 in Q1 2023.
- The 5-year median for Net Cash Flow is -$19000.0 (2024), against an average of -$2450.0.
- Across the five-year window, Net Cash Flow soared 570.0% in 2023 and slumped 330.14% in 2024, its largest moves.
- Raphael Pharmaceutical's Net Cash Flow stood at $116000.0 in 2021, then jumped by 68.1% to $195000.0 in 2022, then slumped by 135.38% to -$69000.0 in 2023, then jumped by 69.57% to -$21000.0 in 2024, then surged by 300.0% to $42000.0 in 2025.
- The last three Net Cash Flow figures came in at $42000.0 (Q4 2025), -$17000.0 (Q3 2025), and -$30000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | Raphael Pharmaceutical | - | - | - | 42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | -17,000.00 |
| Sep 30, 2025 | -17,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | -21,000.00 |
| Dec 31, 2024 | -21,000.00 |
| Sep 30, 2024 | -80,000.00 |
| Sep 30, 2024 | -80,000.00 |
| Jun 30, 2024 | -168,000.00 |
| Jun 30, 2024 | -168,000.00 |
| Mar 31, 2024 | 57,000.00 |
| Mar 31, 2024 | 57,000.00 |
| Dec 31, 2023 | -69,000.00 |
| Dec 31, 2023 | -69,000.00 |
| Sep 30, 2023 | 188,000.00 |
| Sep 30, 2023 | 188,000.00 |